Literature DB >> 25510286

Circulating cardiac biomarkers and postoperative atrial fibrillation in the OPERA trial.

Serge Masson1, Jason H Y Wu, Caterina Simon, Simona Barlera, Roberto Marchioli, Javier Mariani, Alejandro Macchia, Federico Lombardi, Tarcisio Vago, Aneta Aleksova, Lorella Dreas, Roberto R Favaloro, Alejandro R Hershson, John D Puskas, Luca Dozza, Maria G Silletta, Gianni Tognoni, Dariush Mozaffarian, Roberto Latini.   

Abstract

BACKGROUND: Postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery and predicts increased morbidity and mortality. Identification of patients at high risk of POAF with the help of circulating biomarkers may enable early preventive treatment but data are limited, especially in contemporary surgical patients.
METHODS: Plasma concentrations of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) were measured at enrollment, on the morning of cardiac surgery, at end surgery, and 2 days postsurgery in 562 patients undergoing cardiac surgery, randomized to perioperative supplementation with oral fish oil or placebo in the Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial (OPERA). The primary endpoint was incident POAF lasting ≥ 30 s, centrally adjudicated and confirmed electrocardiographically.
RESULTS: Higher levels of NT-proBNP and hs-cTnT before surgery were associated with older age, renal or cardiac dysfunction and EuroSCORE. NT-proBNP peaked on postoperative day 2 (2172 [1238-3758] ng/L, median [Q1-Q3]), while hs-cTnT peaked at the end of surgery (373 [188-660] ng/L). Fish oil supplementation did not alter the time course of the cardiac biomarkers (P > 0.05). Concentrations of NT-proBNP or hs-cTnT, on the morning of surgery, or changes in their level between morning of surgery and postsurgery, were not significantly associated with POAF after adjustment for clinical and surgical characteristics.
CONCLUSION: Among patients undergoing cardiac surgery, NT-proBNP and hs-cTnT are related to clinical and surgical characteristics, have different perioperative time courses but are not independently associated with risk of POAF.
© 2014 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Cardiac surgery; N-terminal pro-B-type natriuretic peptide; fish oil; high-sensitive cardiac troponin; postoperative atrial fibrillation

Mesh:

Substances:

Year:  2015        PMID: 25510286     DOI: 10.1111/eci.12393

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

1.  Prospective Evaluation of Clinico-Pathological Predictors of Postoperative Atrial Fibrillation: An Ancillary Study From the OPERA Trial.

Authors:  Domenico Corradi; Jeffrey E Saffitz; Deborah Novelli; Angeliki Asimaki; Caterina Simon; Emanuela Oldoni; Serge Masson; Jennifer M T A Meessen; Rodolfo Monaco; Roberta Manuguerra; Roberto Latini; Peter Libby; Luigi Tavazzi; Roberto Marchioli; Luca Dozza; Laura Cavallotti; Aneta Aleksova; Renato Gregorini; Dariush Mozaffarian
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-07-12

2.  Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?

Authors:  Francesco Orso; Gianna Fabbri; Aldo Pietro Maggioni
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-12-01

Review 3.  High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease.

Authors:  Cian P McCarthy; Omair Yousuf; Alvaro Alonso; Elizabeth Selvin; Hugh Calkins; John W McEvoy
Journal:  Am J Cardiol       Date:  2017-02-09       Impact factor: 2.778

4.  ScaI atrial natriuretic peptide gene polymorphisms and their possible association with postoperative atrial fibrillation - a preliminary report.

Authors:  Janusz Siebert; Łukasz Lewicki; Jolanta Myśliwska; Monika Młotkowska; Jan Rogowski
Journal:  Arch Med Sci       Date:  2016-05-12       Impact factor: 3.318

Review 5.  Biomarkers of Atrial Fibrillation: Which One Is a True Marker?

Authors:  Pipin Ardhianto; Yoga Yuniadi
Journal:  Cardiol Res Pract       Date:  2019-04-01       Impact factor: 1.866

Review 6.  Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology.

Authors:  Iacopo Fabiani; Alessandro Colombo; Giulia Bacchiani; Carlo Maria Cipolla; Daniela Maria Cardinale
Journal:  J Clin Med       Date:  2019-12-23       Impact factor: 4.241

7.  Noninvasive biomarker-based risk stratification for development of new onset atrial fibrillation after coronary artery bypass surgery.

Authors:  Farhan Rizvi; Mahek Mirza; Susan Olet; Melissa Albrecht; Stacie Edwards; Larisa Emelyanova; David Kress; Gracious R Ross; Ekhson Holmuhamedov; A Jamil Tajik; Bijoy K Khandheria; Arshad Jahangir
Journal:  Int J Cardiol       Date:  2020-01-07       Impact factor: 4.164

8.  The impact of volume substitution on post-operative atrial fibrillation.

Authors:  Sebastian Schnaubelt; Arnold Pilz; Lorenz Koller; Niema Kazem; Felix Hofer; Tatjana Fleck; Günther Laufer; Barbara Steinlechner; Alexander Niessner; Patrick Sulzgruber
Journal:  Eur J Clin Invest       Date:  2020-12-03       Impact factor: 4.686

9.  Echocardiographically Measured Epicardial Fat Predicts New-onset Atrial Fibrillation after Cardiac Surgery.

Authors:  Ertugrul Emre Gunturk; Mustafa Topuz; Faruk Serhatlioğlu; Hasan Akkaya
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.